Ifp Advisors, Inc Novartis Ag Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Novartis Ag stock. As of the latest transaction made, Ifp Advisors, Inc holds 2,460 shares of NVS stock, worth $238,816. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,460

Previous 1,484 65.77%

Holding current value

$238,816

Previous $143,000 82.52%

% of portfolio

0.01%

Previous 0.01%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$92.57 - $107.37 $90,348 - $104,793	976 Added 65.77%	2,460 $261,000
Q1 2024 Jul 30, 2024	SELL	$95.27 - $108.47 $98,604 - $112,266	-1,035 Reduced 41.09%	1,484 $143,000
Q4 2023 Jan 09, 2024	SELL	$92.27 - $101.54 $135,267 - $148,857	-1,466 Reduced 36.79%	2,519 $254,000
Q3 2023 Oct 12, 2023	BUY	$94.73 - $105.13 $176,766 - $196,172	1,866 Added 88.06%	3,985 $405,000
Q2 2023 Aug 04, 2023	SELL	$92.52 - $104.91 $91,317 - $103,546	-987 Reduced 31.78%	2,119 $213,000
Q1 2023 Apr 18, 2023	SELL	$80.03 - $92.81 $294,990 - $342,097	-3,686 Reduced 54.27%	3,106 $285,000
Q4 2022 Feb 07, 2023	SELL	$75.55 - $92.52 $71,092 - $87,061	-941 Reduced 12.17%	6,792 $425,000
Q3 2022 Nov 08, 2022	SELL	$74.61 - $87.26 $5,744 - $6,719	-77 Reduced 0.99%	7,733 $484,000
Q2 2022 Sep 06, 2022	BUY	$80.52 - $93.75 $628,861 - $732,187	7,810 New	7,810 $488,000
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $628,861 - $732,187	-7,810 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$80.11 - $90.62 $376,517 - $425,914	4,700 Added 151.13%	7,810 $685,000
Q1 2022 Aug 08, 2022	BUY	$80.11 - $90.62 $42,057 - $47,575	525 Added 20.31%	3,110 $272,000
Q4 2021 Jan 12, 2022	SELL	$79.7 - $88.13 $24,467 - $27,055	-307 Reduced 10.62%	2,585 $229,000
Q3 2021 Oct 06, 2021	BUY	$81.78 - $95.14 $108,440 - $126,155	1,326 Added 84.67%	2,892 $236,000
Q2 2021 Jul 13, 2021	BUY	$85.24 - $94.15 $16,707 - $18,453	196 Added 14.31%	1,566 $143,000
Q1 2021 Apr 30, 2021	BUY	$83.5 - $98.47 $3,924 - $4,628	47 Added 3.55%	1,370 $120,000
Q4 2020 Jan 25, 2021	SELL	$78.07 - $94.43 $20,298 - $24,551	-260 Reduced 16.42%	1,323 $125,000
Q3 2020 Oct 29, 2020	SELL	$82.14 - $91.0 $22,506 - $24,934	-274 Reduced 14.75%	1,583 $139,000
Q2 2020 Aug 05, 2020	SELL	$80.93 - $91.1 $31,077 - $34,982	-384 Reduced 17.14%	1,857 $163,000
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $100,210 - $140,396	-1,418 Reduced 38.75%	2,241 $179,000
Q4 2019 Jan 17, 2020	SELL	$84.35 - $95.37 $9,025 - $10,204	-107 Reduced 2.84%	3,659 $348,000
Q3 2019 Nov 07, 2019	BUY	$85.54 - $94.26 $169,112 - $186,352	1,977 Added 110.51%	3,766 $327,000
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $727,515 - $832,122	-9,659 Reduced 84.37%	1,789 $176,000
Q4 2018 Jan 23, 2019	BUY	$73.66 - $82.02 $35,135 - $39,123	477 Added 4.35%	11,448 $880,000
Q3 2018 Oct 25, 2018	BUY	$66.94 - $77.43 $265,885 - $307,551	3,972 Added 56.75%	10,971 $0
Q2 2018 Aug 07, 2018	SELL	$64.91 - $73.36 $104,505 - $118,109	-1,610 Reduced 18.7%	6,999 $0
Q1 2018 Jun 03, 2019	SELL	$70.39 - $84.15 $17,175 - $20,532	-244 Reduced 2.76%	8,609 $723,000
Q1 2018 May 09, 2018	BUY	$70.39 - $84.15 $17,175 - $20,532	244 Added 2.83%	8,853 $0
Q4 2017 Jan 24, 2018	SELL	$72.33 - $77.64 $264,004 - $283,386	-3,650 Reduced 29.77%	8,609 $0
Q3 2017 Oct 30, 2017	BUY	$74.14 - $77.27 $23,428 - $24,417	316 Added 2.65%	12,259 $1.05 Million
Q2 2017 Jun 03, 2019	SELL	N/A	-74 Reduced 0.62%	11,943 $997,000
Q1 2017 Jun 03, 2019	BUY	N/A	119 Added 1.0%	12,017 $892,000
Q4 2016 Jun 03, 2019	BUY	N/A	5,257 Added 79.16%	11,898 $867,000
Q2 2016 Jun 03, 2019	BUY	N/A	4,852 Added 271.21%	6,641 $548,000
Q1 2016 Jun 03, 2019	BUY	N/A	1,789	1,789 $176,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account